Evolving Natural History of Metastatic Prostate Cancer

Introduction The systemic therapies available to patients with metastatic prostate cancer (mPC) have improved dramatically over the past decade. Anecdotal experience suggests that the increased available lines of therapy have changed the profile of mPC to include a higher prevalence of visceral meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Nafissi, Nellie N, Kosiorek, Heidi E, Butterfield, Richard J, Moore, Cassandra, Ho, Thai, Singh, Parminder, Bryce, Alan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735525/
https://www.ncbi.nlm.nih.gov/pubmed/33329980
http://dx.doi.org/10.7759/cureus.11484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735525/
https://www.ncbi.nlm.nih.gov/pubmed/33329980
http://dx.doi.org/10.7759/cureus.11484

Ejemplares similares